Extended treatment duration and recurrence in successfully treated drug-susceptible pulmonary tuberculosis with cavity on chest radiograph
PLOS One · 2026
DOI: 10.1371/journal.pone.0357772 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PLOS One, 2026. Verfasst von Chang-Seok Yoon und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Antitubercular Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chonnam National University Hospital Biomedical Research Institute..
Abstract (Originalsprache)
Background
Cavity on chest radiograph is recognized as an independent risk factor for recurrence in pulmonary tuberculosis (TB), but evidence supporting extended treatment in these patients remains limited, particularly in real-world data from Korea.
Methods
We performed a retrospective analysis using data from a multicenter prospective cohort of patients with pulmonary tuberculosis enrolled at 18 Korean institutions, comparing recurrence rates between standard treatment (≤200 days) and extended treatment (>200 days) among drug-susceptible pulmonary TB patients with cavity on chest radiograph.
Results
Among 159 patients, 58 (36.5%) received standard treatment and 101 (63.5%) received extended treatment. Baseline sputum smear positivity was higher in the extended group (29.3% vs. 56.4%, p = 0.002), but 2-month culture positivity (6.3% vs. 4.4%, p > 0.999) and time to culture conversion (8.00 ± 3.91 vs. 7.45 ± 3.73 weeks, p = 0.454) were similar. Recurrence during post-treatment follow-up occurred in 4 patients (2.5%) and did not differ between groups (3.4% vs. 2.0%, p = 0.966). Treatment interruption due to adverse drug reactions was more frequent with extended treatment (1.7% vs. 7.9%, p = 0.204), while overall adverse event rates were comparable. In a fixed-time analysis using Firth’s penalized logistic regression, extended treatment showed a numerically lower risk of recurrence, although statistical significance was not reached (adjusted odds ratio [aOR], 0.07; 95% confidence interval [CI], 0.01–1.06; p = 0.056). Among covariates, low body mass index was associated with recurrence, but this estimate was very imprecise and should be interpreted with caution.
Conclusion
Cavity on chest radiograph alone may not be sufficient to justify routine extension of treatment beyond 200 days. Because only four recurrence events were observed, the adjusted association favoring extended treatment was imprecise and should be interpreted as exploratory rather than definitive. Larger prospective studies that systematically capture microbiologic response and detailed radiologic disease burden are needed to identify which patients with cavitary disease may benefit from individualized treatment extension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Republic of Korea.
ORCID-Profile: Chang-Seok Yoon, Sung Soo Jung, Seunghoon Kim, Hyeon-Kyoung Koo, Yong-Soo Kwon
Förderung
- Chonnam National University Hospital Biomedical Research Institute.
Zitieren
APA
Yoon, C. S., Kim, T. O., Shin, H. J., Kim, J. S., Kim, H. W., Lee, E. G., Jung, S. S., Oh, J. Y., Kim, J. W., Lee, H., Kim, S., Kim, S. H., Park, Y., Lyu, J., Kwon, S. J., Jeong, Y. J., Kim, D. J., Koo, H. K., Chae, G., …, & Kwon, Y. S. (2026). Extended treatment duration and recurrence in successfully treated drug-susceptible pulmonary tuberculosis with cavity on chest radiograph. PLOS One. https://doi.org/10.1371/journal.pone.0357772
Vancouver
Yoon CS, Kim TO, Shin HJ, Kim JS, Kim HW, Lee EG, et al. Extended treatment duration and recurrence in successfully treated drug-susceptible pulmonary tuberculosis with cavity on chest radiograph. PLOS One. 2026. doi:10.1371/journal.pone.0357772
BibTeX
@article{Yoon2026,
author = {Yoon, Chang-Seok and Kim, Tae-Ok and Shin, Hong-Joon and Kim, Ju Sang and Kim, Hyung Woo and Lee, Eung Gu and Jung, Sung Soo and Oh, Jee Youn and Kim, Jin Woo and Lee, Heayon and Kim, Seunghoon and Kim, Sun-Hyung and Park, Yeonhee and Lyu, Jiwon and Kwon, Sun Jung and Jeong, Yun-Jeong and Kim, Do Jin and Koo, Hyeon-Kyoung and Chae, Ganghee and Kyung, Sun Young and Min, Jinsoo and Kwon, Yong-Soo},
title = {Extended treatment duration and recurrence in successfully treated drug-susceptible pulmonary tuberculosis with cavity on chest radiograph},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357772}
}
EUVIMED